- Home
- BOLT vs LRE Comparison
BOLT vs LRE Comparison
Compare BOLT & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- LRE
- Stock Information
- Founded
- BOLT 2015
- LRE 2001
- Country
- BOLT United States
- LRE Japan
- Employees
- BOLT N/A
- LRE N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- BOLT Health Care
- LRE
- Exchange
- BOLT Nasdaq
- LRE Nasdaq
- Market Cap
- BOLT 16.8M
- LRE 18.3M
- IPO Year
- BOLT 2021
- LRE 2023
- Fundamental
- Price
- BOLT $0.40
- LRE $1.25
- Analyst Decision
- BOLT Hold
- LRE
- Analyst Count
- BOLT 5
- LRE 0
- Target Price
- BOLT $1.13
- LRE N/A
- AVG Volume (30 Days)
- BOLT 146.3K
- LRE 2.6K
- Earning Date
- BOLT 05-13-2025
- LRE 01-01-0001
- Dividend Yield
- BOLT N/A
- LRE N/A
- EPS Growth
- BOLT N/A
- LRE N/A
- EPS
- BOLT N/A
- LRE 0.29
- Revenue
- BOLT $7,690,000.00
- LRE $117,804,154.00
- Revenue This Year
- BOLT N/A
- LRE N/A
- Revenue Next Year
- BOLT $77.45
- LRE N/A
- P/E Ratio
- BOLT N/A
- LRE $4.20
- Revenue Growth
- BOLT N/A
- LRE 8.82
- 52 Week Low
- BOLT $0.38
- LRE $1.10
- 52 Week High
- BOLT $1.48
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- BOLT 40.42
- LRE 50.02
- Support Level
- BOLT $0.38
- LRE $1.19
- Resistance Level
- BOLT $0.47
- LRE $1.26
- Average True Range (ATR)
- BOLT 0.04
- LRE 0.04
- MACD
- BOLT -0.00
- LRE 0.03
- Stochastic Oscillator
- BOLT 18.81
- LRE 82.37
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.